Omar L Francone

Title: The Innovations of Omar L Francone

Introduction

Omar L Francone is a notable inventor based in East Lyme, CT (US). He has made significant contributions to the field of medical science, particularly in the treatment of hypertriglyceridemic-related conditions. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Francone's latest patents include a groundbreaking invention titled "Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis." This patent focuses on a lipoprotein lipase (LPL) protein designed to treat and prevent hypertriglyceridemia (HTG) and its associated diseases, including acute pancreatitis. His second patent, "Assay for ABCA1," relates to novel methods for measuring the activity and levels of ABCA1 protein, utilizing acceptors of ABCA1 substrates and measuring ABCA1 mRNA and protein levels.

Career Highlights

Throughout his career, Francone has worked with prominent companies such as Pfizer Corporation and Shire Human Genetic Therapies, Inc. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.

Collaborations

Some of his notable coworkers include Mark J Bamberger and Lin Guey. Their collaboration has likely fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Omar L Francone's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical health conditions.